Immuno-epigenetic escape of cancer stem cells

Lorenzo Galluzzi^{1

2

3}, Guido Kroemer^{4

5

6}

Affiliations

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.
² Sandra and Edward Meyer Cancer Center, New York, NY, USA. deadoc80@gmail.com.
³ Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. deadoc80@gmail.com.
⁴ Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. kroemer@orange.fr.
⁵ Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France. kroemer@orange.fr.
⁶ Institut du Cancer Paris CARPEM, Department of Biology, APHP, Hôpital Européen Georges Pompidou, Paris, France. kroemer@orange.fr.

Comment

Lorenzo Galluzzi et al. Nat Immunol. 2022 Sep.

. 2022 Sep;23(9):1300-1302.

doi: 10.1038/s41590-022-01293-0.

Lorenzo Galluzzi^{1

2

3}, Guido Kroemer^{4

5

6}

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.
² Sandra and Edward Meyer Cancer Center, New York, NY, USA. deadoc80@gmail.com.
³ Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. deadoc80@gmail.com.
⁴ Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. kroemer@orange.fr.
⁵ Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France. kroemer@orange.fr.
⁶ Institut du Cancer Paris CARPEM, Department of Biology, APHP, Hôpital Européen Georges Pompidou, Paris, France. kroemer@orange.fr.

No abstract available

Comment on

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.

1. McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O’Garra, A. Nat. Rev. Immunol. 15, 87–103 (2015). - DOI
1. Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Nat. Immunol. 23, 487–500 (2022). - DOI
1. Musella, M. et al. Nat. Immunol. https://doi.org/10.1038/s41590-022-01290-3 (2022). - DOI - PubMed
1. Sistigu, A. et al. Nat. Med. 20, 1301–1309 (2014). - DOI
1. Yamazaki, T. et al. Nat. Immunol. 21, 1160–1171 (2020). - DOI